Research ArticleArticle
RVX-297, a BET bromodomain inhibitor, has therapeutic effects in preclinical models of acute inflammation and autoimmune disease
Ravi Jahagirdar, Sarah Attwell, Suzana Marusic, Alison Bendele, Narmada Shenoy, Kevin G McLure, Dean Gilham, Karen Norek, Henrik C Hansen, Raymond Yu, Jennifer Tobin, Gregory S Wagner, Peter R Young, Norman CW Wong and Ewelina Kulikowski
Molecular Pharmacology September 29, 2017, mol.117.110379; DOI: https://doi.org/10.1124/mol.117.110379
Ravi Jahagirdar
1 Resverlogix Corp.;
Sarah Attwell
1 Resverlogix Corp.;
Suzana Marusic
2 Hooke Laboratories Inc.;
Alison Bendele
3 Bolder BioPATH Inc.;
Narmada Shenoy
4 Aravasc Inc.
Kevin G McLure
1 Resverlogix Corp.;
Dean Gilham
1 Resverlogix Corp.;
Karen Norek
1 Resverlogix Corp.;
Henrik C Hansen
1 Resverlogix Corp.;
Raymond Yu
1 Resverlogix Corp.;
Jennifer Tobin
1 Resverlogix Corp.;
Gregory S Wagner
1 Resverlogix Corp.;
Peter R Young
1 Resverlogix Corp.;
Norman CW Wong
1 Resverlogix Corp.;
Ewelina Kulikowski
1 Resverlogix Corp.;
Article Figures & Data
Additional Files
Data Supplement
- Supplemental Data -
Supplemental Table 1 - Circulating Inflammatory Mediators in LPS Stimulated Mice
Supplemental Figure 1 - Mouse Collagen Induced Arthritis (mCIA)
- Supplemental Data -
In this issue
Research ArticleArticle
RVX-297, a BET bromodomain inhibitor, has therapeutic effects in preclinical models of acute inflammation and autoimmune disease
Ravi Jahagirdar, Sarah Attwell, Suzana Marusic, Alison Bendele, Narmada Shenoy, Kevin G McLure, Dean Gilham, Karen Norek, Henrik C Hansen, Raymond Yu, Jennifer Tobin, Gregory S Wagner, Peter R Young, Norman CW Wong and Ewelina Kulikowski
Molecular Pharmacology September 29, 2017, mol.117.110379; DOI: https://doi.org/10.1124/mol.117.110379
Research ArticleArticle
RVX-297, a BET bromodomain inhibitor, has therapeutic effects in preclinical models of acute inflammation and autoimmune disease
Ravi Jahagirdar, Sarah Attwell, Suzana Marusic, Alison Bendele, Narmada Shenoy, Kevin G McLure, Dean Gilham, Karen Norek, Henrik C Hansen, Raymond Yu, Jennifer Tobin, Gregory S Wagner, Peter R Young, Norman CW Wong and Ewelina Kulikowski
Molecular Pharmacology September 29, 2017, mol.117.110379; DOI: https://doi.org/10.1124/mol.117.110379
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement